The treatment of benign prostatic hyperplasia: a prospective, randomized clinical trial to be conducted by the American Urological Association

H. Logan Holtgrewe

Research output: Contribution to journalArticlepeer-review

Abstract

Through a large nationwide, multicenter, prospective, randomized and preferential clinical trial, the American Urological Association plans to evaluate the efficacy of watchful waiting, alpha-blockade, balloon dilation, and transurethral prostatectomy (TURP) in the treatment of benign prostatic hyperplasia. The study, to be conducted at 20 major urological centers in the United States, will primarily address the issue of long-term mortality after TURP and for the first time in any large clinical trial, will evaluate the effect of these management strategies on the patient's quality of life. Completion of the study should provide valuable information, now lacking in the urological literature, concerning the treatment of the most common urological disease of the aging male.

Original languageEnglish (US)
Pages (from-to)218-223
Number of pages6
JournalWorld journal of urology
Volume8
Issue number4
DOIs
StatePublished - Dec 1 1990

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'The treatment of benign prostatic hyperplasia: a prospective, randomized clinical trial to be conducted by the American Urological Association'. Together they form a unique fingerprint.

Cite this